IJCS | Volume 32, Nº2, March/April 2019

124 25. Oemrawsingh RM, Cheng JM, Akkerhuis KM, Kardys I, Degertekin M, van Geuns RJ, et al. High-sensitivity C-reactive protein predicts 10- year cardiovascular outcome after percutaneous coronary intervention. EuroIntervention. 2016;12(3):345-51. 26. Klingenberg R, Aghlmandi S, Räber L, Gencer B, Nanchen D, Heg D, et al. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score. Eur Heart J Acute Cardiovasc Care. 2018;7(2):129-38. 27. Yanishi K, Nakamura T, Nakanishi N, Yokota I, Zen K, Yamano T, et al. A Simple risk stratificationmodel for ST-ElevationMyocardial Infarction (STEMI) from the combination of blood examination variables: acute myocardial infarction-KyotoMulti-Center Risk Study Group. PLoS ONE. 2016;11(11):e0166391. 28. Correia LC, Vasconcelos I, Garcia G, Kalil F, Ferreira F, Silva A, et al. Does C-reactive protein add prognostic value to GRACE score in acute coronary syndromes? Arq Bras Cardiol. 2014;102(5):449-55. 29. Ahmed K, Jeong MH, Chakraborty R, Cho KH, Sim DS, Hong YJ, et al. Prognostic impact of baseline high-sensitivityC-reactive protein inpatients with acute myocardial infarction undergoing percutaneous coronary intervention based on body mass index. Korean Circ J. 2012;42(3):164-72. 30. Vrsalovic M, Pintaric H, Babic Z, Pavlov M, Presecki AV, Getaldic B, et al. Impact of admission anemia, Creactive protein and mean platelet volume on short term mortality in patients with acute ST-elevation myocardial infarction treated with primary angioplasty. Clin Biochem. 2012;45(16-17):1506-9. 31. MouridsenMR, Intzilakis T, Binici Z, NielsenOW, SajadiehA. Prognostic value of high sensitive C-reactive protein in subjects with silent myocardial ischemia. J Electrocardiol. 2012;45(3):260-4. 32. Raposeiras-Roubín S, Pardal CB, Janeiro BR, Abu-Assi E, García-Acuña JM, González-Juanatey JR. High-sensitivity C-reactive protein is a predictor of in-hospital cardiac events in acute myocardial infarction independently of GRACE risk score. Angiology. 2012;63(1):30-4. 33. Tanveer S, Banu S, Jabir NR, Khan MS, Ashraf GM, Manjunath NC, et al. Clinical and angiographic correlation of high‑sensitivity C‑reactive protein with acute ST elevation myocardial infarction. Exp Ther Med. 2016;12(6):4089–98. 34. Schiele F, Meneveau N, Seronde MF, Chopard R, Descotes-Genon V, Dutheil J et al. C‑reactive protein improves risk prediction in patients with acute coronary syndromes. Eur Heart J. 2010;31(3):290‑7. 35. Widera C, Pencina MJ, Bobadilla M, Reimann I, Guba-Quint A, Marquardt I, et al. Incremental prognostic value of biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) score and high-sensitivity cardiac troponin T in non-ST-elevation acute coronary syndrome. Clin Chem. 2013;59(10):1497–505. 36. Teixeira DA, Sousa CFP, Pereira GLH, Maia LFL, Teixeira FH, Lisita CLF. C-reactive protein: association between inflammation and complication after acute myocardial infarction in the elderly. Rev Bras Clin Med. 2009;7:24-26. Milano et al. C-reactive protein as a predictor of mortality Int J Cardiovasc Sci. 2019;32(2)118-124 Original Article This is an open-access article distributed under the terms of the Creative Commons Attribution License